je.st
news
Home
› KBI Biopharma Selects Freeslate's Biologics Formulation System For Early And Late Stage Drug Development
KBI Biopharma Selects Freeslate's Biologics Formulation System For Early And Late Stage Drug Development
2013-09-04 06:58:35| drugdiscoveryonline News Articles
Freeslate, Inc., the leading provider of high throughput research solutions, today announced that KBI Biopharma, Inc. (KBI), a leading development and contract manufacturing organization serving the biopharmaceutical industry, has purchased Freeslate’s Biologics Formulation System to help develop more robust formulations using less time and material
Tags: system
development
early
late
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||